345 related articles for article (PubMed ID: 35138444)
1. Quantitative classification and radiomics of [
de Koster EJ; Noortman WA; Mostert JM; Booij J; Brouwer CB; de Keizer B; de Klerk JMH; Oyen WJG; van Velden FHP; de Geus-Oei LF; Vriens D;
Eur J Nucl Med Mol Imaging; 2022 Jun; 49(7):2174-2188. PubMed ID: 35138444
[TBL] [Abstract][Full Text] [Related]
2. [
de Koster EJ; de Geus-Oei LF; Brouwers AH; van Dam EWCM; Dijkhorst-Oei LT; van Engen-van Grunsven ACH; van den Hout WB; Klooker TK; Netea-Maier RT; Snel M; Oyen WJG; Vriens D;
Eur J Nucl Med Mol Imaging; 2022 May; 49(6):1970-1984. PubMed ID: 34981165
[TBL] [Abstract][Full Text] [Related]
3. Molecular Diagnostics and [
de Koster EJ; Morreau H; Bleumink GS; van Engen-van Grunsven ACH; de Geus-Oei LF; Links TP; Wakelkamp IMMJ; Oyen WJG; Vriens D
Thyroid; 2024 Jan; 34(1):41-53. PubMed ID: 38009209
[No Abstract] [Full Text] [Related]
4. [
de Koster EJ; van Engen-van Grunsven ACH; Bussink J; Frielink C; de Geus-Oei LF; Kusters B; Peters H; Oyen WJG; Vriens D;
Mol Imaging Biol; 2023 Jun; 25(3):483-494. PubMed ID: 36253663
[TBL] [Abstract][Full Text] [Related]
5. Is (18)F-fluorodeoxyglucose-PET/CT useful for the presurgical characterization of thyroid nodules with indeterminate fine needle aspiration cytology?
Deandreis D; Al Ghuzlan A; Auperin A; Vielh P; Caillou B; Chami L; Lumbroso J; Travagli JP; Hartl D; Baudin E; Schlumberger M; Leboulleux S
Thyroid; 2012 Feb; 22(2):165-72. PubMed ID: 22257371
[TBL] [Abstract][Full Text] [Related]
6. FDG-PET/CT in indeterminate thyroid nodules: cost-utility analysis alongside a randomised controlled trial.
de Koster EJ; Vriens D; van Aken MO; Dijkhorst-Oei LT; Oyen WJG; Peeters RP; Schepers A; de Geus-Oei LF; van den Hout WB;
Eur J Nucl Med Mol Imaging; 2022 Aug; 49(10):3452-3469. PubMed ID: 35435497
[TBL] [Abstract][Full Text] [Related]
7. FDG-PET characteristics of Hürthle cell and follicular adenomas.
Pathak KA; Klonisch T; Nason RW; Leslie WD
Ann Nucl Med; 2016 Aug; 30(7):506-9. PubMed ID: 27221817
[TBL] [Abstract][Full Text] [Related]
8. Indeterminate thyroid cytology in an iodine-deficient population: Prevalence, operation rate, risk of malignancy anddiagnostic value of thyroid scintigraphy and
Almasi CE; Frandsen AP; Erentaite D; Duch K; Zacho HD
Hell J Nucl Med; 2023; 26(1):2-8. PubMed ID: 37031417
[TBL] [Abstract][Full Text] [Related]
9. Ability of
Ou X; Wang J; Zhou R; Zhu S; Pang F; Zhou Y; Tian R; Ma X
Contrast Media Mol Imaging; 2019; 2019():4507694. PubMed ID: 30930700
[No Abstract] [Full Text] [Related]
10. Is there a role for fluorodeoxyglucose positron emission tomography/computed tomography in cytologically indeterminate thyroid nodules?
Hales NW; Krempl GA; Medina JE
Am J Otolaryngol; 2008; 29(2):113-8. PubMed ID: 18314022
[TBL] [Abstract][Full Text] [Related]
11. Indeterminate thyroid nodules. The role of
Piccardo A; Puntoni M; Dezzana M; Bottoni G; Foppiani L; Marugo A; Catrambone U; Ugolini M; Sola S; Gatto M; Treglia G; Giovanella L; Trimboli P
Endocrine; 2020 Sep; 69(3):553-561. PubMed ID: 32124261
[TBL] [Abstract][Full Text] [Related]
12. Examining the Role of Preoperative Positron Emission Tomography/Computerized Tomography in Combination with Ultrasonography in Discriminating Benign from Malignant Cytologically Indeterminate Thyroid Nodules.
Merten MM; Castro MR; Zhang J; Durski J; Ryder M
Thyroid; 2017 Jan; 27(1):95-102. PubMed ID: 27762671
[TBL] [Abstract][Full Text] [Related]
13. Radiomics analysis improves
Giovanella L; Milan L; Piccardo A; Bottoni G; Cuzzocrea M; Paone G; Ceriani L
Endocrine; 2022 Jan; 75(1):202-210. PubMed ID: 34468949
[TBL] [Abstract][Full Text] [Related]
14. Hounsfield unit value has null effect on thyroid nodules at 18F-FDG PET/CT scans.
Haydardedeoglu FE; Bagir GS; Torun N; Kocer E; Reyhan M; Ertorer ME
Arch Endocrinol Metab; 2018 Aug; 62(4):460-465. PubMed ID: 30304111
[TBL] [Abstract][Full Text] [Related]
15. Could 18F-FDG-PET/CT avoid unnecessary thyroidectomies in patients with cytological diagnosis of follicular neoplasm?
Muñoz Pérez N; Villar del Moral JM; Muros Fuentes MA; López de la Torre M; Arcelus Martínez JI; Becerra Massare P; Esteva Martínez D; Cañadas Garre M; Coll Del Rey E; Bueno Laraño P; Ferrón Orihuela JA
Langenbecks Arch Surg; 2013 Jun; 398(5):709-16. PubMed ID: 23624819
[TBL] [Abstract][Full Text] [Related]
16.
Ruhlmann M; Ruhlmann J; Görges R; Herrmann K; Antoch G; Keller HW; Ruhlmann V
Thyroid; 2017 Oct; 27(10):1300-1306. PubMed ID: 28793848
[TBL] [Abstract][Full Text] [Related]
17. Radiomics based on
Ou X; Zhang J; Wang J; Pang F; Wang Y; Wei X; Ma X
Cancer Med; 2020 Jan; 9(2):496-506. PubMed ID: 31769230
[TBL] [Abstract][Full Text] [Related]
18. Characterization of focal hypermetabolic thyroid incidentaloma: An analysis with F-18 fluorodeoxyglucose positron emission tomography/computed tomography parameters.
Lee H; Chung YS; Lee JH; Lee KY; Hwang KH
World J Clin Cases; 2022 Jan; 10(1):155-165. PubMed ID: 35071515
[TBL] [Abstract][Full Text] [Related]
19. Comparison of 18F-FDG-PET and 18F-FDG-PET/CT for the diagnostic performance in thyroid nodules with indeterminate cytology: A meta-analysis.
Qichang W; Jinming S; Lu L; Bin J; Renjie W; Xiuying Z
Medicine (Baltimore); 2020 May; 99(22):e20446. PubMed ID: 32481449
[TBL] [Abstract][Full Text] [Related]
20. Exclusion of malignancy in thyroid nodules with indeterminate fine-needle aspiration cytology after negative 18F-fluorodeoxyglucose positron emission tomography: interim analysis.
Traugott AL; Dehdashti F; Trinkaus K; Cohen M; Fialkowski E; Quayle F; Hussain H; Davila R; Ylagan L; Moley JF
World J Surg; 2010 Jun; 34(6):1247-53. PubMed ID: 20140435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
